Literature DB >> 15363605

Ephrin signaling in axon guidance.

Jacques Huot1.   

Abstract

The multiple functions of a neuron depend on the proper assembly of axonal connections during the development of the nervous systems. This assembly involves the motile behavior of growth cones at the ends of elongating axons. The growth cones express receptors that bind to specific guidance molecules in the local environment. In turn, this initiates the attractive and repulsive forces required to give the appropriate direction to the elongating axon. The process implicates a tightly regulated remodeling of the actin cytoskeleton in response to the activation of the Rho GTPases, Cdc42, Rac and RhoA. In this article, we will review how the ephrin-Eph receptor system regulates the activity of the Rho GTPases, to modulate the mechanics of growth cone activity and then axon guidance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363605     DOI: 10.1016/j.pnpbp.2004.05.025

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  16 in total

1.  Genome-based expression profiles as a single standardized microarray platform for the diagnosis of experimental interstitial cystitis: an array of 75 genes model.

Authors:  Ling-Hong Tseng; Ilene Chen; Ming-Yang Chen; Chyi-Long Lee; Tsia-Shu Lo; L Keith Lloyd
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-01-20

2.  EphA4 signaling regulates blastomere adhesion in the Xenopus embryo by recruiting Pak1 to suppress Cdc42 function.

Authors:  Nicolas Bisson; Luc Poitras; Alexander Mikryukov; Michel Tremblay; Tom Moss
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

3.  DNA Methylation of the EphA5 Promoter Is Associated with Rat Congenital Hypothyroidism.

Authors:  Youjia Wu; Honghua Song; Baolan Sun; Meiyu Xu; Jinlong Shi
Journal:  J Mol Neurosci       Date:  2015-06-25       Impact factor: 3.444

4.  Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors.

Authors:  Ayman Oweida; Shilpa Bhatia; Kellen Hirsch; Dylan Calame; Anastacia Griego; Steve Keysar; Todd Pitts; Jaspreet Sharma; Gail Eckhardt; Antonio Jimeno; Xiao Jing Wang; Gill Parkash; Joseph Califano; Sana D Karam
Journal:  Mol Carcinog       Date:  2016-11-01       Impact factor: 4.784

5.  Attenuation of ephrinB2 reverse signaling decreases vascularized area and preretinal vascular tuft formation in the murine model of oxygen-induced retinopathy.

Authors:  Alyssa C Taylor; Thomas A Mendel; Katelyn E Mason; Katherine E Degen; Paul A Yates; Shayn M Peirce
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-13       Impact factor: 4.799

6.  Expression of PTPRO in the interneurons of adult mouse olfactory bulb.

Authors:  Takenori Kotani; Yoji Murata; Hiroshi Ohnishi; Munemasa Mori; Shinya Kusakari; Yasuyuki Saito; Hideki Okazawa; John L Bixby; Takashi Matozaki
Journal:  J Comp Neurol       Date:  2010-01-10       Impact factor: 3.215

7.  Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion.

Authors:  Dominique B Hoelzinger; Mitsutoshi Nakada; Tim Demuth; Tyler Rosensteel; Linsey B Reavie; Michael E Berens
Journal:  J Neurooncol       Date:  2007-10-11       Impact factor: 4.130

8.  Benefit of chondroitinase ABC on sensory axon regeneration in a laceration model of spinal cord injury in the rat.

Authors:  Lisa B E Shields; Yi Ping Zhang; Darlene A Burke; Rebecca Gray; Christopher B Shields
Journal:  Surg Neurol       Date:  2008-06

9.  Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling.

Authors:  Anastasios Georgakopoulos; Claudia Litterst; Enrico Ghersi; Lia Baki; ChiJie Xu; Geo Serban; Nikolaos K Robakis
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

10.  Eph regulates dorsoventral asymmetry of the notochord plate and convergent extension-mediated notochord formation.

Authors:  Izumi Oda-Ishii; Yasuo Ishii; Takashi Mikawa
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.